OpenFDA Drug Search by nexgendata

Query the FDA's open data platform for drug adverse events, medication labels, drug recalls, and medical device reports. This actor wraps the OpenFDA API to deliver structured pharmaceutical data without requiring API key setup, pagination logic, or custom parsing code. Search by drug name, active ingredient, or manufacturer and receive clean JSON records ready for analysis.

The Food and Drug Administration maintains the most comprehensive database of drug safety information in the world. The FDA Adverse Event Reporting System (FAERS) contains millions of reports from healthcare professionals, consumers, and manufacturers about suspected side effects and medication errors. Drug labeling data includes every approved medication's indications, warnings, dosage instructions, and active ingredients. The enforcement database tracks every drug recall with classification severity and distribution scope. This actor makes all of that data accessible through simple keyword searches.

How It Works

Choose a data type — adverse events, drug labels, recalls, or medical devices — and provide a search term. The actor queries the appropriate OpenFDA endpoint and returns structured records. For adverse events, each record includes the drug name, manufacturer, reported reactions, patient demographics, seriousness classification, and reporting country. For drug labels, you get brand names, generic names, indications, warnings, dosage information, and route of administration. Recall data includes the recalling firm, reason for recall, FDA classification (Class I through III), and geographic distribution pattern.

The OpenFDA API serves data without authentication for up to 240 requests per minute. This actor handles the query formatting, response parsing, and data normalization so you receive consistently structured output regardless of which data type you search. No API keys to register, no rate limit management, no response format variations to handle.

Who Uses This

Pharmaceutical companies monitor adverse event reports for drugs in their portfolio and for competitor products. Pharmacovigilance teams track safety signals that might indicate emerging risks. Clinical researchers query FAERS data to study drug interactions and population-specific side effect profiles. Health economists use recall data and adverse event frequencies to model the true cost of medication safety issues.

Regulatory consultants need rapid access to enforcement actions and recall histories when advising clients on FDA compliance. Healthcare providers check adverse event databases when investigating unusual patient reactions. Academic researchers studying drug safety epidemiology use FAERS data as a primary data source for signal detection studies and pharmacoepidemiological research.

Insurance companies and pharmacy benefit managers analyze adverse event data to inform formulary decisions and risk assessments. Legal teams involved in pharmaceutical litigation use FAERS data to establish patterns of harm and evaluate the scope of reported injuries.

What You Get Back

Adverse event records include the drug name, manufacturer, list of reported reactions (coded in MedDRA terminology), seriousness flag, patient age and sex, outcome information, report type, and country of occurrence. Label records contain brand name, generic name, manufacturer, indications, warnings, dosage instructions, route of administration, substance names, and product type. Recall records show the product description, recalling firm, recall reason, FDA classification, status, date, location, and distribution pattern. Device records include device name, manufacturer, event type, report date, and event description.

Pricing

This actor costs $3 per 1,000 results. Monitoring a single drug's adverse events (100 results) costs $0.30. A comprehensive safety review pulling 5,000 records across multiple drugs runs $15. Compared to commercial pharmaceutical data services that charge thousands per dataset, this provides direct FDA data access at commodity pricing.